DA32 Life Science Tech Acquisition Corp.
DA32 Life Science Tech Acquisition Corp. (DALS) Revenue
Annual & quarterly revenue history · segment & region breakdown
DALS · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsDA32 Life Science Tech Acquisition Corp. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income DA32 Life Science Tech Acquisition Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
DA32 Life Science Tech Acquisition Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from DA32 Life Science Tech Acquisition Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
DALS revenue · 4 questionsDALS's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · DA32 Life Science Tech Acquisition Corp. SEC filings · GAAP · DA32 Life Science Tech Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026